Tongling Bionic Raises Hundreds of Millions in Series B Financing for Cardiopulmonary Equipment Development
Anhui Tongling Bionic Technology Co., Ltd, a Chinese developer of cardiopulmonary circulatory assist equipment, has...
Sesen Bio Terminates Vicineum Development After FDA Talks, Citing Phase III Costs
Sesen Bio Inc. (NASDAQ: SESN) announced the termination of clinical development for Vicineum (VB4-845), its...
Huadong Medicine’s GFR Monitoring System Accepted by NMPA for Review
China-based Huadong Medicine Co., Ltd (SHE: 000963) announced that its market filing for a glomerular...
Roche’s Chugai Launches Edirol in China for Postmenopausal Osteoporosis
Swiss pharma giant Roche’s subsidiary Chugai Pharmaceutical Co Ltd has officially launched Edirol (eldecalcitol), an...
Humanwell Healthcare’s RFUS-144 Wins NMPA Approval for Pruritus Clinical Study
China-based Humanwell Healthcare (Group) Co., Ltd (SHA: 600079) announced that its Category 1 drug RFUS-144...
Brii Biosciences Partners with Huarun Medicine to Commercialize COVID-19 Antibody Cocktail in China
China-based Brii Biosciences Ltd (HKG: 2137) announced a partnership with Huarun Medicine Business Group International...
Hengrui Medicine Launches Revelutamide for Metastatic Prostate Cancer in China
Hengrui Medicine has launched revelutamide (SHR3680; trade name: Erion), China’s homegrown innovative androgen receptor (AR)...
Chongqing Lummy Pharma Cancels YZY Biopharma Y400 Partnership, Secures Compensation
China’s Chongqing Lummy Pharmaceutical Co., Ltd (SHE: 300006) announced the termination of its strategic partnership...
HutchMed Initiates Phase I Study of CD47 Monoclonal Antibody HMPL-A83 in China
China-based HutchMed (NASDAQ: HCM, HKG: 0013) announced the initiation of a Phase I clinical study...
Grand Pharma Acquires Stake in Xeltis and Licenses aXess for Hemodialysis in Greater China
China-based Grand Pharmaceutical Group Limited (HKG: 0512) announced the acquisition of an 11% stake in...
Fermion Secures Series B Financing to Advance AI-Driven Drug Development
Guangzhou-based AI biotech Fermion has raised over RMB100 million ($14.8 million) in a Series B...
Biotree Raises $14.8M in Series A Financing to Expand Multi-Omics Platform
Shanghai-based multi-omics specialist Biotree has raised nearly RMB100 million ($14.8 million) in a Series A...
Kexing Pharmaceutical’s SHEN26 COVID-19 Drug Receives NMPA Approval for Clinical Trials
China-based Kexing Pharmaceutical (SHA: 688136) announced that its oral small-molecule COVID-19 drug SHEN26, co-developed with...
WeDoctor Partners with Jinan Innovation Zone to Launch Dual Healthcare Platform
China-based WeDoctor Holdings Ltd, a Tencent-backed online medical service platform, has partnered with Jinan Innovation...
ImmuneOnco’s IMM2902 Receives FDA Fast-Track Designation for CD47/HER2 Targeting
ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd announced that the U.S. Food and Drug Administration (FDA) has...
VBP Round 7 Drug Procurement Contract Awards Top Winners Revealed
China’s 7th national Volume-Based Procurement (VBP) round concluded with winning bids for 60 drug products...
Merck KGaA Launches Uptune Program in Asia, Offers Startups Up to €100,000
Germany-based life sciences giant Merck KGaA has launched the Uptune program in Asia, offering up...
Pfizer Launches Cejemly in China for Stage III NSCLC, Expands Immunotherapy Reach
Pfizer announced the commercial launch of Cejemly (sugemalimab) in China for Stage III non-small cell...
Sihuan Pharma to Sell Generic Drug Businesses, Shift Focus to Aesthetics and Biologics
China’s Sihuan Pharmaceutical Holdings Group Ltd (HKG: 0460) announced plans to divest a portion of...
Luye Pharma’s Lurbinectedin Receives Hainan Approval for SCLC Treatment
China-based Luye Pharma Group (HKG: 2186) announced approval from the Hainan Medical Products Administration for...